Revenue grew 0.8% from the year-ago quarter to $2.46 billion, below the Capital IQ Consensus Estimate of $2.51 billion for the quarter. The company reported earnings of $1.92 a share for the second quarter, 8 cents above analysts' estimates of $1.84 a share.
Gross margin fell to 26.7% in quarter, down from 27.7% in the year-ago quarter.
Must read: Warren Buffett's 25 Favorite Stocks
TheStreet Ratings team rates EASTMAN CHEMICAL CO as a Buy with a ratings score of A. TheStreet Ratings Team has this to say about their recommendation:
"We rate EASTMAN CHEMICAL CO (EMN) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its notable return on equity, attractive valuation levels and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows low profit margins."